v3.8.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2018
Dec. 31, 2017
Current assets    
Cash and cash equivalents $ 15,173 $ 12,821
Accounts receivable 58,129 60,427
Inventories 7,515 7,474
Other current assets 6,954 5,153
Total current assets 87,771 85,875
Property and equipment (net of accumulated depreciation of $44,024 and $40,530, respectively. 40,411 36,504
Intangible assets, net 72,751 74,165
Goodwill 147,019 147,019
Other assets 1,320 891
Total assets 349,272 344,454
Current liabilities    
Accounts payable 13,048 10,450
Accrued compensation 10,164 9,482
Accrued expenses and other liabilities 9,884 7,550
Short-term portion of capital leases and car loans 5,988 5,239
Short-term portion of loans 4,219 3,750
Total current liabilities 43,303 36,471
Long-term liabilities    
Long-term portion of capital leases and car loans 6,515 5,303
Long-term portion of loans, net 65,208 66,616
Revolving credit facility, net 19,114 24,516
Long-term pharma contract liability 522 283
Deferred income tax liability, net 6,594 6,688
Total long-term liabilities 97,953 103,406
Total liabilities 141,256 139,877
Commitments and contingencies
Redeemable convertible preferred stock    
Series A Redeemable Convertible Preferred Stock, $0.001 par value, (50,000,000 shares authorized; 6,864,000 shares issued and outstanding) 35,471 32,615
Stockholders' equity    
Common stock, $0.001 par value, (250,000,000 shares authorized; 80,568,453 and 80,462,574 shares issued and outstanding, respectively) 81 80
Additional paid-in capital 232,039 230,030
Accumulated other comprehensive income 499 274
Accumulated deficit (60,074) (58,422)
Total stockholders’ equity 172,545 171,962
Total liabilities, redeemable convertible preferred stock and stockholders' equity $ 349,272 $ 344,454

Source